 |
As today’s biotechnology companies navigate the many complexities of clinical research, they’re frequently challenged to make otherwise immature financial systems more sophisticated and supportive of pre-commercialization activities, compliance needs, and go-to-market timelines. On top of that, many biotech companies are themselves leaner and potentially geographically dispersed, making it even harder to embrace an enterprise-wide approach without disrupting their everyday clinical workflows. The solution? Business Spend Management (BSM). In this webinar, we’ll examine how clinical-stage biotechnology company, Arvinas, partnered with Coupa and Sikich to transform its financial systems for a more integrated and streamlined process. You’ll learn:
|
